Company / Return on Assets (ROA)
Tandem Diabetes Care Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-23.2%
FY2025
5-year range
-23.4% / -2.7%
FY2021-FY2025
Trend
-134.2%
vs FY2024
Sector context
#148 of 159
Health Care
What the data says
Among 159 Health Care companies, Tandem Diabetes Care is in the bottom 7% for return on assets (roa). Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -75.9% in FY2017 to -2.7% in FY2021.
Based on SEC 10-K filings.
-23.2% in FY2025 with a 5-year CAGR of -6.1%.
Remained stable around -23.2% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -20.0pp
- 5-Year Change
- -6.1pp
- 10-Year Change
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 159This company -23.2% Sector average -2.2%
▼
-950.2% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 134.2% year-over-year.
- Currently 21.0pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2021.
- Lowest return on assets (roa) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -23.2% | -134.2% |
| FY2024 | -9.9% | +57.6% |
| FY2023 | -23.4% | -614.7% |
| FY2022 | -3.3% | -19.8% |
| FY2021 | -2.7% | +84.0% |
| FY2020 | -17.1% | +23.6% |
| FY2019 | -22.4% | +44.6% |
| FY2018 | -40.5% | +46.7% |
| FY2017 | -75.9% | -2.3% |
| FY2016 | -74.3% | -27.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026